Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | Q9HBH1 | 6/20 | 0.47 | |
| ▸ | MMP3 | P08254 | 11/20 | 0.39 |
| ▸ | MMP2 | P08253 | 9/20 | 0.39 |
| ▸ | MMP1 | P03956 | 9/20 | 0.39 |
| ▸ | MMP7 | P09237 | 4/20 | 0.39 |
| ▸ | MMP9 | P14780 | 2/20 | 0.38 |
| ▸ | CTSK | P43235 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6135699 | 0.89 | PDF (0.53) | PDFMMP3MMP2MMP1MMP7 | |
| SCHEMBL14282179 | 0.88 | PDF (0.54) | PDFMMP3MMP2MMP1MMP7 | |
| SCHEMBL14282181 | 0.80 | PDF (0.52) | PDFMMP3MMP2MMP1 | |
| SCHEMBL14282180 | 0.79 | PDF (0.51) | PDFCTSK | |
| SCHEMBL13333323 | 0.79 | PDF (0.51) | PDFMMP3MMP2MMP1 | |
| SCHEMBL14573451 | 0.79 | MMP2 (0.44) | MMP3MMP2MMP1MMP9 | |
| SCHEMBL13333267 | 0.78 | LMNA (0.45) | MMP3MMP2 | |
| SCHEMBL14282182 | 0.78 | PDF (0.50) | ||
| SCHEMBL14282184 | 0.76 | PDF (0.48) | ||
| SCHEMBL6053340 | 0.75 | PDF (0.47) |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100125075-A1 | Antibacterial Agents | BRITISH BIOTECH PHARMACEUTICALS LTD. (GB) | 2010-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100125075-A1 | Antibacterial Agents | NQO2, DAO, Q6ZSR9 | PDF 273/4885MMP3 3780/4885MMP2 1579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.